Skip to content

Koh Bong Y

Reporting owner on Forms 3, 4 and 5, CIK 1615979.

Koh Bong Y reported on 1 issuer in 4 filings, the latest a Form 4 filed 2026-11-04.

Issuers

IssuerRoles in the latest filingFilingsLast filed
Lycia Therapeutics, Inc. CIK 180654010% owner42026-11-04

Transactions and holdings

Every row of the person's Forms 3, 4 and 5, newest first, with the price and the amount owned after the row as filed.

SecurityDateCodeSharesPriceOwned afterFiling
Lycia Therapeutics, Inc. Common Stock2026-11-02P bought+8,305$26.956,858,542Form 4
Lycia Therapeutics, Inc. Common Stock2026-10-30P bought+8,804$26.276,850,037Form 4
Lycia Therapeutics, Inc. Common Stock2026-10-30P bought+200$26.866,850,237Form 4
Lycia Therapeutics, Inc. Common Stock2026-10-29P bought+1,000$26.336,841,233Form 4
Lycia Therapeutics, Inc. Common Stock2026-10-28P bought+10,570$25.236,835,803Form 4
Lycia Therapeutics, Inc. Common Stock2026-10-28P bought+4,430$25.976,840,233Form 4
Lycia Therapeutics, Inc. Common Stock2026-10-27P bought+8,729$25.846,794,166Form 4
Lycia Therapeutics, Inc. Common Stock2026-10-27P bought+31,067$26.846,825,233Form 4
Lycia Therapeutics, Inc. Common Stock2026-10-26C converted+4,779,7934,832,732Form 4
Lycia Therapeutics, Inc. Common Stock2026-10-26P bought+1,944,444$186,777,176Form 4
Lycia Therapeutics, Inc. Common Stock2026-10-26P bought+8,261$26.976,785,437Form 4
Lycia Therapeutics, Inc. Series C Preferred Stock, derivative2026-10-26C converted-17,142,578$00Form 4
Lycia Therapeutics, Inc. Series D Preferred Stock, derivative2026-10-26C converted-4,408,091$00Form 4
Lycia Therapeutics, Inc. Common Stock2026-10-23P bought+24,560$25.6824,560Form 4
Lycia Therapeutics, Inc. Common Stock2026-10-23P bought+28,379$26.1152,939Form 4
Lycia Therapeutics, Inc. Series C Preferred Stock, derivative, holding Form 3
Lycia Therapeutics, Inc. Series D Preferred Stock, derivative, holding Form 3

Filings

The person's Forms 3, 4 and 5, and any 13D or 13G naming it.

FilingSubjectFiledAcceptedIngested
Form 4 0001231919-26-001536 Lycia Therapeutics, Inc.2026-11-04
Form 4 0001231919-26-001519 Lycia Therapeutics, Inc.2026-10-30
Form 4 0001231919-26-001503 Lycia Therapeutics, Inc.2026-10-27
Form 3 0001231919-26-001493 Lycia Therapeutics, Inc.2026-10-22